Showing results (171-180 of 1,692) with videos related to
Sort By:
Pageof 170
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1993
Destructive spondyloarthropathy in a patient on continuous ambulatory peritoneal dialysis for 13 yearsG E Digenis, G Davidson, N V Dombros, et al.Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1989
Splenic abscess and peritonitis in a continuous ambulatory peritoneal dialysis (CAPD) patientP Blake, G Abraham, J Bargman, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 30, 2001
Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal functionM K Menon, D M Naimark, J M Bargman, et al.The Journal of Urology|July 1, 1978
Studies in inhibitors of calcification and levels of urine saturation with calcium salts in recurrent stone patientsP O Crassweller, D G Oreopoulos, A Toguri, et al.Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1991
Single-dose pefloxacin pharmacokinetics and metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD)P Nikolaidis, S E Walker, N Dombros, et al.Scanning Electron Microscopy|January 1, 1983
Ultrastructural studies of renal stones from patients on continuous ambulatory peritoneal dialysisP T Cheng, A Reid, J Millard, et al.Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 15, 1998
Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit siteE Thodis, S Bhaskaran, P Pasadakis, et al.British Medical Bulletin|November 27, 2001
Depresssion--emerging insights from neurobiologyV A Vaidya, R S DumanNeuron|April 30, 2003
Finding the intracellular signaling pathways affected by mood disorder treatmentsJoseph T Coyle, Ronald S DumanNeuroscience|January 1, 1996
The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterizationA Y Deutch, R S DumanPageof 170